These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 21545506

  • 1. Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis.
    Shintani Y, Kaneko N, Furuhashi T, Saito C, Morita A.
    J Dermatol; 2011 Oct; 38(10):966-72. PubMed ID: 21545506
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris.
    Hashizume H, Ito T, Yagi H, Takigawa M, Kageyama H, Furukawa F, Hata M, Shirahama S, Tanaka M, Higashishiba T, Machida H, Tsushima T, Matsushita K.
    J Dermatol; 2007 Jul; 34(7):430-4. PubMed ID: 17584318
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I, Nakayama J, Murakami H, Hori Y, Higuchi S.
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [Abstract] [Full Text] [Related]

  • 4. Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy.
    Ito T, Furukawa F, Iwatsuki K, Matsue H, Shimada S, Takigawa M, Tokura Y.
    J Dermatol; 2014 May; 41(5):377-81. PubMed ID: 24628433
    [Abstract] [Full Text] [Related]

  • 5. Low-dose, short-term ciclosporin (Neoral®) therapy is effective in improving patients' quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients.
    Okubo Y, Natsume S, Usui K, Amaya M, Tsuboi R.
    J Dermatol; 2011 May; 38(5):465-72. PubMed ID: 21352289
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
    Zachariae H, Abrams B, Bleehen SS, Bräutigam M, Burrows D, Ettelt MJ, Fry L, Happle R, Haustein UF, Ganslandt J, Jung EG, Knop J, Kühne KH, Mellein B, Mørk NJ, Rogers S, Schmidt AG, Schopf RE, Sumner M, Taube KM, Weidinger G, Wurdel C, Zahn E.
    Dermatology; 1998 May; 196(2):231-6. PubMed ID: 9568413
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R, Sánchez Regaña M, Massana J, Oliete R, Umbert P.
    J Dermatolog Treat; 2005 May; 16(4):238-41. PubMed ID: 16249146
    [Abstract] [Full Text] [Related]

  • 12. Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris.
    Abe M, Ishibuchi H, Syuto T, Sogabe Y, Yokoyama Y, Ishikawa O.
    J Dermatol; 2007 May; 34(5):290-3. PubMed ID: 17408436
    [Abstract] [Full Text] [Related]

  • 13. Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapy.
    Hashimoto T, Kawakami T, Tsuruta D, Hamada T, Natsuaki Y, Fukuda S, Koga H, Sogame R, Ohyama B, Ono F, Karashima T, Nakama T, Dainichi T, Ishii N, Yasumoto S.
    Australas J Dermatol; 2012 Aug; 53(3):202-6. PubMed ID: 22881466
    [Abstract] [Full Text] [Related]

  • 14. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A, Horike K, Onoda H, Ohtsuka Y, Yoshida A, Uchida K, Morozumi K.
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intermittent cyclosporin A treatment of severe plaque psoriasis. Long-term follow-up of 26 patients.
    Peluso AM, Bardazzi F, Tosti A, Varotti C.
    Acta Derm Venereol Suppl (Stockh); 1994 Apr; 186():90-1. PubMed ID: 8073851
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial.
    Flytström I, Stenberg B, Svensson A, Bergbrant IM.
    Br J Dermatol; 2008 Jan; 158(1):116-21. PubMed ID: 17986302
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.